Cimetidine: definition and structure

Cimetidine is a histamine congener which inhibits the binding of histamine competitively to H2 receptors. After its binding to the H2 receptor, cimetidine causes a range of pharmacological responses through the inhibition of secretion of gastric acid by parietal cells as well as gastrin and pepsin output. Cimetidine also acts to block cytochrome P-450 activity and it may therefore be used in future as a neoadjuvant therapy.

Cimetidine reduces the nocturnal and basal secretion of gastric acid and also reduces acidity, gastric volume as well as the amount of released acid upon particular stimuli such as caffeine, food, betazole, insulin and pentagastrin. The structure of cimetidine (Fig 1. 3) permits it to competitively bind to the H2 receptors, the target for histamine. Cimetidine is used in the management of duodenal and gastric ulcers, pathological hepersecretory and gastroesophageol reflux conditions.

The inhibition of cytochrome P-450 has raised increased attention as it interferes with the metabolism of drugs and other xenobiotics. Fig 1. 3 Structure of Cimetidine Fig 1. 3 The structure of cimetidine gives it the competitive ability to bind to H2 receptors just like histamine [8] Conclusion The studies of receptor-ligand interactions have been critical in areas of pharmaceutical research.

The analysis of physical properties of compounds has moved a whole new level where computer-assisted designs can be made and extrapolated to the real-life situation. Molecules can be interacted with a number of receptors using computer software to come up with conclusive report. This approach of drug discovery is fast and does not face ethical issues surrounding the animal and human experiments.

Bibliography:

Smith, MJ. , Leurs, RL. , Alewinjnse, AE. , Blauw, J. , Van Nieuw Amerongen, GP. , De Vrede, YV. , Roovers, E. , & Timmerman, H.Inverse agonism of histamine H2 antagonists accounts for upregulation of spontaneously active histamine H2 receptors, Proc. Natl. Acad. Sci. USA, 1996; 93: 6802-6807 Valle, JD & Grantz, I. Novel insights into histamine H2 receptor biology. Am J Physiol Gastrointest Liver Physiol 1997; 273(5): G987-G996 Vogel, HG. Drug Discovery and Evaluation: Pharmacological Assays. New York: Springer, 2008 Kobilka, BK. G protein coupled receptor structure and activation. Biochemical and Biophysics Academy, 2007; 1768 (4): 794-807

Cimetidine is the most prototypical drug ever to be tested and shown to have exciting antagonistic properties with histamine H2-receptor. After GlaxoSmithKline’s development in about mid 1960s, a number of histamine H2 receptor antagonists have been developed. H2 receptor antagonists …

Histamine binds to the pockets of the alpha helixes of the transmembrane histamine H2 receptor. Within the phopholipid bilayer of the plasma membrane, there is a specific pocket for small lipophillic biogenic amines. Agonists (histamine) and antagonists (cimetidine) bind to …

The precursor of gastrin ‘preprogastrin’ can be converted into several types of gastrin hormones, namely, G-34, G-17, and G-14, depending on the number of amino acid that are attached. The carboxyl terminal tetrapepetide contain more than 45 amino acids residues …

?*These effects are also observed after the ingestion of spoiled fish (scombroid fish poisoning), and histamine produced by bacterial action in the flesh of the fish is the major causative agent. ?Contraindications: ?Patients with: ?asthma (except as part of a …

David from Healtheappointments:

Hi there, would you like to get such a paper? How about receiving a customized one? Check it out https://goo.gl/chNgQy